25 Aug 2025
💊FDA Announces Public Meeting on Drug User Fee Act and Hiring Assessment
Prescription Drug User Fee Act and Biosimilar User Fee Amendments Hiring and Retention Assessment; Public Meeting; Request for Comments
Summary
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Prescription Drug User Fee Act and Biosimilar User Fee Amendments Hiring and Retention Assessment." The topic to be discussed is a hiring and retention assessment which was performed by an independent contractor.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$ - Med
The document involves business compliance and regulatory requirements related to the Prescription Drug User Fee Act and hiring assessments, which can affect pharmaceutical companies. There are implications for businesses in terms of understanding FDA hiring practices and their impact on drug review timelines.